C9orf72 and amyotrophic lateral sclerosis: Taken together, studies have identified that C9-ALS/FTD patients may possess an altered immunophenotype due to both C9orf72 haploinsufficiency and HRE-associated toxicity that is associated with heightened DNA damage and subsequent activation of the STING pathway.